Current status and challenges of biologic targeted therapy for myasthenia gravis in China
公開日: 2026/02/26 |
15 巻
1 号
p. 45-53
Shengying Gu, Chongbo Zhao
2
Frailty in older adults: A systematic review of risk factors and early intervention pathways
公開日: 2025/06/10 |
14 巻
2 号
p. 93-108
Yi Deng, Katsuya Yamauchi, Peipei Song, Takashi Karako
3
How to evaluate rare disease policy effectiveness based on policy modeling consistency (PMC) index model: A quantitative assessment of policy implementation in China
Comparative analysis of adverse event reporting signals between Satralizumab and Inebilizumab in neuromyelitis optica spectrum disorder: A pharmacovigilance study using the FDA Adverse Event Reporting System
